Alzheimer's drug fails to reduce significant agitation
Wednesday, May 2, 2012 - 20:30
in Health & Medicine
A drug prescribed for Alzheimer's disease does not ease clinically significant agitation in patients, according to first randomized controlled trial designed to assess the effectiveness of the drug (generic name memantine) for significant agitation in Alzheimer's patients.